Multiple endocrine neoplasia type 2 (MEN2) is a rare hereditary disorder that affects the endocrine glands. Doctors mainly associate MEN2 with tumors of the adrenal gland, the thyroid, and the ...

Multiple endocrine neoplasia (MEN) is a group of rare genetic conditions that increase the risk of certain tumors in your glands. Parathyroid, thyroid, adrenal glands, and digestive tract tumors are ...

A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators at ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. More than half of patients with multiple endocrine ...

Analyses of the immunologically relevant gene transcript by qRT-PCR in primary cutaneous melanoma by the young and the elderly. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.

Multiple endocrine neoplasia (MEN) describes a group of rare genetic disorders that affect the body's hormone-producing glands. MEN type 1 usually affects the parathyroid gland(s), the pituitary gland ...

Medullary thyroid carcinoma (MTC)—a cancer of the calcitonin-secreting parafollicular C-cells—is the most common cause of death in the hereditary syndrome multiple endocrine neoplasia type 2A (MEN2A).

Please provide your email address to receive an email when new articles are posted on . An AACE consensus statement outlines treatment recommendations for MEN1-associated tumors and genetic testing.

Multiple Endocrine Neoplasia Type 1 is a rare genetic disorder associated with a high risk of developing tumors in your parathyroid gland and pituitary gland, and your pancreas. Multiple endocrine ...

Multiple endocrine neoplasia type 1 (MEN1) is a genetic condition that causes tumors to form in endocrine glands and other organs. Despite not usually being cancerous, these tumors can be very ...

A new targeted drug has not only sparked remissions in patients with a common form of leukemia but also induced the cancer cells to reveal one of their schemes for resisting the drug, investigators at ...